Study of ALXN2050 in Participants With Hepatic Impairment - NCT05259085

Area Under The Concentration-time Curve From Time 0 To The 12-hour Time Point (AUC0-12) Of Plasma ALXN2050 After Steady-state, Area Under The Concentration-time Curve Calculated To The Last Observable Concentration At Time t (AUCt) Of Plasma ALXN2050 After Steady-state, Maximum (Peak) Steady-state Plasma Concentration Of ALXN2050 (Cmax,ss), (and 2 more...)